Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is ...
Leadership
Matthew Pauls J.D., M.B.A.
Chairman & CEO
David L. Lowrance CPA
Chief Financial & Administrative Officer and Secretary
Robert Matthew Lutz M.B.A.
Chief Operating Officer
Yasmine Wasfi M.D., Ph.D.
Chief Medical Officer
Kate McCabe J.D.
Chief Legal Officer
Anne Erickson
Chief Business & Corporate Affairs Officer
Brian Maurer
Head of Clinical Operations
Charles LaPree
Executive VP & Head of Global Regulatory Affairs
Brian Robinson M.D.
Executive Vice President of Global Medical Affairs
Siddharth J. Advant Ph.D.
Executive Vice President of Global Technical Operations
